• 1 Introduction 6
• 1.1 Industry Definition and Research Scope 6
• 1.1.1 Industry Definition 6
• 1.1.2 Research Scope 7
• 1.2 Research Methodology 10
• 1.2.1 Overview of Market Research Methodology 10
• 1.2.2 Market Assumption 11
• 1.2.3 Secondary Data 11
• 1.2.4 Primary Data 11
• 1.2.5 Data Filtration and Model Design 13
• 1.2.6 Market Size/Share Estimation 14
• 1.2.7 Research Limitations 15
• 1.3 Executive Summary 16
• 2 Market Overview and Dynamics 18
• 2.1 Market Size and Forecast 18
• 2.2 Major Growth Drivers 19
• 2.3 Market Restraints and Challenges 22
• 2.4 Emerging Opportunities and Market Trends 25
• 2.5 Porter’s Fiver Forces Analysis 29
• 3 Segmentation of Asia Pacific Market by Product 33
• 3.1 Market Overview by Product 33
• 3.2 Vaccines 35
• 3.2.1 Anthrax 38
• 3.2.2 Smallpox 39
• 3.2.3 Botulism 40
• 3.2.4 Nuclear/Radiation 41
• 3.2.5 E-Bola 42
• 3.2.6 Zika 43
• 3.2.7 Other Vaccines 44
• 3.3 Biothreat Detection Devices 45
• 3.4 Antibiotics 47
• 3.5 Masks 48
• 3.6 Other Products 49
• 4 Segmentation of Asia Pacific Market by Sales Channel 50
• 4.1 Market Overview by Sales Channel 50
• 4.2 Online Sales 52
• 4.3 Offline Sales 53
• 5 Segmentation of Asia Pacific Market by Application 54
• 5.1 Market Overview by Application 54
• 5.2 Military 56
• 5.3 Civilian 57
• 6 Asia-Pacific Market 2019-2030 by Country 58
• 6.1 Overview of Asia-Pacific Market 58
• 6.2 Japan 61
• 6.3 China 64
• 6.4 Australia 66
• 6.5 India 68
• 6.6 South Korea 70
• 6.7 Rest of APAC Region 72
• 7 Competitive Landscape 74
• 7.1 Overview of Key Vendors 74
• 7.2 New Product Launch, Partnership, Investment, and M&A 77
• 7.3 Company Profiles 78
• Achaogen, Inc. 78
• Alexeter Technologies LLC 80
• Alnylam Pharmaceuticals, Inc. 81
• Altimmune, Inc. 82
• Bavarian Nordic AS 83
• BioFactura, Inc. 84
• Cleveland Biolabs, Inc. 85
• Dynavax Technologies Inc 86
• Dynport Vaccine Company LLC (DVC) 87
• Elusys Therapeutics, Inc. 88
• Emergent BioSolutions Inc 89
• General Dynamics Corp. 90
• GlaxoSmithKline Plc 91
• Ichor Medical Systems 92
• Mediimmune (AstraZeneca) 93
• Nanotherapeutics, Inc. 94
• Ology Bioscience 95
• PathSensors Inc 96
• Pluristem Therapeutics 97
• Sanofi Pasteur Ltd. 98
• SIGA Technologies, Inc. 99
• Soligenix, Inc. 100
• Xoma Corporation 101
• 8 Investing in Asia Pacific Market: Risk Assessment and Management 102
• 8.1 Risk Evaluation of Asia Pacific Market 102
• 8.2 Critical Success Factors (CSFs) 105
• Related Reports and Products 108

Figure 1. Research Method Flow Chart 10
Figure 2. Breakdown of Primary Research 12
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 16
Figure 5. Asia Pacific Biodefense Market, 2019-2030, $ mn 18
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Biodefense Market 19
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Biodefense Market 22
Figure 8. Investment Opportunity Analysis 26
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Biodefense Market 29
Figure 10. Breakdown of Asia Pacific Biodefense Market by Product, 2019-2030, % of Sales Revenue 33
Figure 11. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%) 34
Figure 12. Asia Pacific Biodefense Market: Vaccines, 2019-2030, $ mn 35
Figure 13. Asia Pacific Biodefense Market: Anthrax, 2019-2030, $ mn 38
Figure 14. Asia Pacific Biodefense Market: Smallpox, 2019-2030, $ mn 39
Figure 15. Asia Pacific Biodefense Market: Botulism, 2019-2030, $ mn 40
Figure 16. Asia Pacific Biodefense Market: Nuclear/Radiation, 2019-2030, $ mn 41
Figure 17. Asia Pacific Biodefense Market: E-Bola, 2019-2030, $ mn 42
Figure 18. Asia Pacific Biodefense Market: Zika, 2019-2030, $ mn 43
Figure 19. Asia Pacific Biodefense Market: Other Vaccines, 2019-2030, $ mn 44
Figure 20. Asia Pacific Biodefense Market: Biothreat Detection Devices, 2019-2030, $ mn 45
Figure 21. Asia Pacific Biodefense Market: Antibiotics, 2019-2030, $ mn 47
Figure 22. Asia Pacific Biodefense Market: Masks, 2019-2030, $ mn 48
Figure 23. Asia Pacific Biodefense Market: Other Products, 2019-2030, $ mn 49
Figure 24. Breakdown of Asia Pacific Biodefense Market by Sales Channel, 2019-2030, % of Sales Revenue 50
Figure 25. Asia Pacific Addressable Market Cap in 2020-2030 by Sales Channel, Value ($ mn) and Share (%) 51
Figure 26. Asia Pacific Biodefense Market: Online Sales, 2019-2030, $ mn 52
Figure 27. Asia Pacific Biodefense Market: Offline Sales, 2019-2030, $ mn 53
Figure 28. Breakdown of Asia Pacific Market by Application, 2019-2030, % of Revenue 54
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%) 55
Figure 30. Asia Pacific Biodefense Market: Military, 2019-2030, $ mn 56
Figure 31. Asia Pacific Biodefense Market: Civilian, 2019-2030, $ mn 57
Figure 32. Breakdown of APAC Biodefense Market by Country, 2019 and 2030, % of Revenue 59
Figure 33. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 60
Figure 34. Biodefense Market in Japan, 2019-2030, $ mn 62
Figure 35. Biodefense Market in China, 2019-2030, $ mn 64
Figure 36. Biodefense Market in Australia, 2019-2030, $ mn 66
Figure 37. Biodefense Market in India, 2019-2030, $ mn 68
Figure 38. Biodefense Market in South Korea, 2019-2030, $ mn 70
Figure 39. Biodefense Market in Rest of APAC, 2019-2030, $ mn 72
Figure 40. Growth Stage of Asia Pacific Biodefense Industry over the Forecast Period 74

Table 1. Snapshot of Asia Pacific Biodefense Market, 2019-2030 17
Table 2. Main Product Trends and Market Opportunities in Asia Pacific Biodefense Market 25
Table 3. Asia Pacific Biodefense Market by Product, 2019-2030, $ mn 33
Table 4. Asia Pacific Biodefense Market: Vaccines by Application, 2019-2030, $ mn 36
Table 5. List of Biodefense Vaccine Pipelines 37
Table 6. Asia Pacific Biodefense Market: Vaccines Biothreat Detection Devices by Type, 2019-2030, $ mn 46
Table 7. Asia Pacific Biodefense Market by Sales Channel, 2019-2030, $ mn 50
Table 8. Asia Pacific Market by Application, 2019-2030, $ mn 54
Table 9. APAC Biodefense Market by Country, 2019-2030, $ mn 59
Table 10. Japan Biodefense Market by Product, 2019-2030, $ mn 63
Table 11. Japan Biodefense Market by Sales Channel, 2019-2030, $ mn 63
Table 12. Japan Biodefense Market by Application, 2019-2030, $ mn 63
Table 13. China Biodefense Market by Product, 2019-2030, $ mn 65
Table 14. China Biodefense Market by Sales Channel, 2019-2030, $ mn 65
Table 15. China Biodefense Market by Application, 2019-2030, $ mn 65
Table 16. Australia Biodefense Market by Product, 2019-2030, $ mn 67
Table 17. Australia Biodefense Market by Sales Channel, 2019-2030, $ mn 67
Table 18. Australia Biodefense Market by Application, 2019-2030, $ mn 67
Table 19. India Biodefense Market by Product, 2019-2030, $ mn 69
Table 20. India Biodefense Market by Sales Channel, 2019-2030, $ mn 69
Table 21. India Biodefense Market by Application, 2019-2030, $ mn 69
Table 22. South Korea Biodefense Market by Product, 2019-2030, $ mn 71
Table 23. South Korea Biodefense Market by Sales Channel, 2019-2030, $ mn 71
Table 24. South Korea Biodefense Market by Application, 2019-2030, $ mn 71
Table 25. Biodefense Market in Rest of APAC by Country, 2019-2030, $ mn 73
Table 26. Achaogen, Inc.: Company Snapshot 78
Table 27. Achaogen, Inc.: Business Segmentation 78
Table 28. Achaogen, Inc.: Product Portfolio 79
Table 29. Achaogen, Inc.: Revenue, 2016-2018, $ mn 79
Table 30. Achaogen, Inc.: Recent Developments 79
Table 31. Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 103
Table 32. Critical Success Factors and Key Takeaways 106